Stock listing

gettex:4XB XBiotech Inc. Aktie

German listing (gettex) of XBiotech Inc. · home listing NASDAQ:XBIT

Follow XBiotech Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:XBIT

$1.73 USD 0.00 (0.0%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:XBIT

Past year -22.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.61 – $1.81 USDNov 20, 2026
Volume
140,203 sharesNov 20, 2026
Market cap
$52.74M USDAt the close on Nov 20, 2026 · price × 30.49M shares outstanding
52-week range
$1.61 – $2.73 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$130,233 USDMedian day 41,957 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
XBiotech Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:XBIT · Home$1.73 USD0.00 (0.0%)140,203$1.68$1.81$1.61$1.73Close on Nov 20, 2026
Frankfurt:4XB€1.546 EUR+0.066 (+4.5%)—€1.38€1.546€1.38€1.48Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:XBIT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.730.000.0%$1.68$1.81$1.61140,203
$1.73-0.05-2.8%$1.77$1.789$1.7160,735
$1.78-0.07-3.8%$1.86$1.87$1.7862,583
$1.85-0.11-5.6%$1.97$1.97$1.81111,272
$1.960.000.0%$1.95$1.99$1.95105,424
$1.96+0.01+0.5%$1.96$1.99$1.9516,242
$1.95-0.02-1.0%$1.945$1.982$1.94518,552
$1.97+0.06+3.1%$1.91$1.98$1.9157,456
$1.91+0.02+1.1%$1.89$1.92$1.8614,540
$1.89+0.02+1.1%$1.88$1.946$1.8625,248
$1.87-0.08-4.1%$1.95$2.005$1.85231,644
$1.95-0.04-2.0%$2.01$2.01$1.9294,251
$1.99+0.07+3.6%$1.90$2.13$1.90132,747
$1.92+0.04+2.1%$1.98$1.99$1.86561,436
$1.88-0.06-3.1%$1.93$1.982$1.86550,560
$1.94-0.05-2.5%$1.98$1.98$1.8773,978
$1.99+0.14+7.6%$1.86$2.04$1.80309,975
$1.850.000.0%$1.85$1.952$1.8169,105
$1.85-0.08-4.1%$1.92$1.927$1.82136,289
$1.93-0.04-2.0%$1.95$1.95$1.86121,736
$1.97-0.02-1.0%$1.98$1.98$1.947,668
$1.99-0.03-1.5%$2.04$2.04$1.9858,251
$2.02+0.02+1.0%$2.03$2.08$1.9941,228
$2.00-0.12-5.7%$2.13$2.13$1.905384,627
$2.12-0.04-1.9%$2.16$2.22$2.1068,271
$2.160.000.0%$2.16$2.26$2.1385,022
$2.160.000.0%$2.16$2.235$2.1566,074
$2.16-0.13-5.7%$2.27$2.29$2.1578,446
$2.290.000.0%$2.29$2.33$2.2541,957
$2.29+0.09+4.1%$2.21$2.29$2.19588,032
$2.20+0.01+0.5%$2.19$2.22$2.1513,021
$2.19+0.03+1.4%$2.16$2.23$2.16100,377
$2.16-0.02-0.9%$2.18$2.19$2.1611,714
$2.18-0.01-0.5%$2.20$2.20$2.1832,740
$2.19-0.01-0.5%$2.20$2.20$2.1925,236
$2.20+0.01+0.5%$2.19$2.20$2.1913,563
$2.19+0.01+0.5%$2.18$2.21$2.1862,849
$2.18+0.03+1.4%$2.13$2.18$2.139,549
$2.15-0.02-0.9%$2.16$2.19$2.1541,689
$2.17+0.01+0.5%$2.156$2.17$2.1510,829
$2.16-0.02-0.9%$2.17$2.19$2.1624,000
$2.180.000.0%$2.19$2.20$2.1740,037
$2.180.000.0%$2.21$2.21$2.189,099
$2.18-0.01-0.5%$2.19$2.20$2.1731,839
$2.19+0.01+0.5%$2.20$2.22$2.1666,092
$2.18+0.03+1.4%$2.17$2.18$2.1432,119
$2.15-0.045-2.1%$2.19$2.22$2.1549,067
$2.195+0.025+1.2%$2.17$2.20$2.1618,231
$2.17-0.02-0.9%$2.20$2.20$2.1721,882
$2.19+0.02+0.9%$2.19$2.21$2.1831,325
$2.17-0.01-0.5%$2.17$2.18$2.1520,270
$2.180.000.0%$2.19$2.27$2.1523,958
$2.18-0.02-0.9%$2.20$2.21$2.1845,362
$2.200.000.0%$2.20$2.25$2.19118,606
$2.20+0.01+0.5%$2.20$2.22$2.19136,189
$2.19-0.03-1.4%$2.22$2.22$2.19109,028
$2.22-0.08-3.5%$2.29$2.309$2.19221,171
$2.30+0.03+1.3%$2.26$2.31$2.2523,051
$2.27-0.03-1.3%$2.32$2.32$2.267,073
$2.30-0.01-0.4%$2.28$2.33$2.2632,783
$2.31+0.01+0.4%$2.30$2.32$2.2921,900
$2.30-0.01-0.4%$2.30$2.32$2.2352,245
$2.31+0.03+1.3%$2.28$2.32$2.2627,778
$2.28-0.03-1.3%$2.26$2.32$2.2611,043
$2.310.000.0%$2.30$2.33$2.2610,039
Ticker
gettex:4XB
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
gettex
Currency
EUR

What changed lately

Latest news

All XBiotech Inc. news

XBiotech Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 49 in all · newest Oct 23, 2026 · oldest 2019
Decks
2 decks · latest Apr 21, 2017

Where XBiotech Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:XBIT · Home listingNASDAQUnited StatesUSD
Lang & Schwarz:A14QF1Lang & SchwarzGermanyEUR
gettex:4XB · This pagegettexGermanyEUR
LS Exchange:A14QF1LS ExchangeGermanyEUR
BOATS:XBITBOATSUnited StatesUSD
BX Swiss:4XBBX SwissSwitzerlandCHF
Frankfurt:4XBFrankfurtGermanyEUR
Tradegate:4XBTradegateGermanyEUR
Dusseldorf:4XBDusseldorfGermanyEUR
Munich:4XBMunichGermanyEUR
Stuttgart:4XBStuttgartGermanyEUR

Valuation

Price/book 0.4× against a median of 0.9×: the lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$52.29M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.4×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.52

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
XBiotech Inc. · NASDAQ:XBITUS$52.74M−US$52.29Mn/an/an/a0.4×n/a0.0×0.52
Island Pharmaceuticals Ltd · ASX:ILAUS$54.84MUS$46.32Mn/a248×n/a6.2×n/a0.0×n/a
Anavex Life Sciences Corp. · NASDAQ:AVXLUS$54.83M−US$63.50Mn/an/an/a0.5×n/a0.0×2.39
Nordicus Partners Corp · OTC:NORDUS$54.44MUS$54.44Mn/an/an/a0.9×n/a0.0×0.45
Boundless Bio, Inc. · NASDAQ:BOLDUS$53.61M−US$9.28Mn/an/an/a0.9×n/a0.0×0.65
Xilio Therapeutics, Inc. · NASDAQ:XLOUS$53.40M−US$62.82Mn/a−1.1×n/a0.8×−20.9%0.1×0.76
Impact BioMedical, Inc. · AMEX:IBOUS$53.31MUS$53.29M33.0×1,402×n/a5.3×n/a0.0×0.06
Bonus Biogroup Ltd. · TASE:BONSUS$52.22MUS$54.52Mn/an/an/an/an/an/an/a
iBio, Inc. · NASDAQ:IBIOUS$51.45M−US$23.13Mn/a−21.5×n/a0.7×n/a0.0×2.01
Sirnaomics Ltd. · HKEX:2257US$51.13MUS$69.20Mn/an/an/an/an/an/an/a
Cinclus Pharma Holding AB · OMXSTO:CINPHAUS$51.07MUS$13.13Mn/a3.8×n/a2.6×−765.8%0.0×n/a
Median of the othersUS$53.36MUS$29.73M33.0×3.8×0.9×−393.3%0.0×0.71

Team and board

Officers

OfficerRole
Sushma ShivaswamyChief Scientific Officer, Interim Chief Executive Officer
Mike CavalierVice President of Manufacturing
Norma GonzalezVice President of Quality
Qian WuSenior Vice President of Clinical Operations and Analytical Quality
John SimardFounder, Chairman of the Board, Scientific Advisor

Board

DirectorRole
John SimardFounder, Chairman of the Board, Scientific Advisor

Events

QuarterResultsShare move
Q3 2026Nov 12, 2026+0.5%
Q2 2026Aug 13, 2026−6.5%
Q4 2025Feb 25, 2026+0.4%
Q3 2025Nov 28, 2025+5.7%
Q2 2025Aug 29, 2025−10.9%
Q1 2025May 8, 2025 · Before open+2.1%
Q4 2024Mar 13, 2025 · Before open−4.6%
Q3 2024Nov 7, 2024 · Before open−10.8%
Q2 2024Aug 12, 2024 · Before open−0.8%
Q1 2024May 10, 2024 · Before open−3.5%
All 20 quarters
QuarterResultsShare move
Q4 2023Mar 15, 2024 · Before open−7.1%
Q3 2023Nov 9, 2023 · Before open−3.2%
Q2 2023Aug 11, 2023 · Before open+0.2%
Q1 2023May 10, 2023 · After close+2.1%
Q4 2022Mar 15, 2023 · After close+1.2%
Q3 2022Nov 9, 2022 · Before open−0.8%
Q2 2022Aug 9, 2022 · After close+0.8%
Q1 2022May 11, 2022−6.6%
Q4 2021Mar 2, 2022+0.5%
Quarter to Sep 30, 2021Nov 11, 2021−3.3%

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (April 2017)Technical37 slidesApr 21, 2017
Investor Presentation (December 2016)Investor deck31 slidesDec 6, 2016

Open Decks

IPO

Priced at US$19.00 a share on Apr 14, 2015.

Price
US$19.00 a share
Shares offered
4,000,000 shares of common stock
Offering size
US$76 million

Steps

StepWhen
Draft sent to the SEC in confidenceDec 10, 2014
Filed publiclyFeb 2, 2015
Amended 3 timesNewest Apr 10, 2015
Shares registered with an exchangeApr 14, 2015
Declared effective by the SECApr 14, 2015
Final prospectus, with the priceApr 16, 2015

Open IPO · From the cover of the final prospectus (424B4) filed Apr 16, 2015

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0004.01M18.4M44.0M0000
Cost of revenue1.69M1.75M0651.0K5.82M34.5M001.48M698.0K
Gross profit-1.69M-1.75M03.36M12.6M9.45M00-1.48M-698.0K
Research and development47.4M37.8M32.8M31.5M28.3M9.53M24.1M15.7M26.4M42.5M
Selling, general and administrative8.29M4.71M4.66M6.30M9.39M18.2M7.14M5.27M7.63M10.3M
Operating income-55.7M-42.5M-37.5M-34.5M-25.1M-18.3M-31.2M-21.0M-34.1M-52.8M
Depreciation and amortization1.69M1.75M1.70M2.61M2.65M2.24M2.36M2.43M1.48M698.0K
EBITDA-54.0M-40.7M-35.8M-31.9M-22.4M-16.0M-28.9M-18.6M-32.6M-52.1M
Interest expense88.0K807.0K0902.0K1.09M8.95M748.8M000
Income before tax-45.3M-38.6M-24.3M-33.6M-25.5M-12.8M718.5M-21.1M-33.1M-52.8M
Income tax235.0K-32.0K244.0K-688.0K-8.04M-1.61M49.8M000
Net income-45.5M-38.5M-24.6M-32.9M-17.4M-11.2M668.6M-21.1M-33.1M-52.8M
Earnings per share, basic-1.49-1.26-0.81-1.08-0.58-0.3617.17-0.59-0.95-1.63
Earnings per share, diluted-1.49-1.26-0.81-1.08-0.58-0.3614.44-0.59-0.95-1.63

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents125.6M172.7M200.0M157.3M237.0M237.4M714.6M15.8M31.8M34.3M
Short-term investments060.2M000
Receivables360.0K700.0K860.0K1.22M04.11M0
Inventory-8.95M-6.57M00
Current assets127.0M174.6M201.7M219.8M246.9M325.9M716.3M17.0M33.3M36.9M
Property, plant and equipment23.1M24.5M24.9M26.3M28.3M27.3M25.2M27.3M29.6M10.1M
Goodwill00
Total assets150.1M199.1M226.6M246.1M275.2M353.7M816.9M44.3M63.0M67.0M
Accounts payable1.53M2.22M2.52M2.41M2.07M2.49M2.15M1.65M1.73M4.43M
Current liabilities7.93M15.1M6.10M4.07M3.45M3.98M60.2M2.94M2.79M7.96M
Long-term debt00
Total debt10.3M
Total liabilities9.73M16.8M7.77M5.70M5.79M5.11M61.2M2.95M2.81M7.99M
Shareholders' equity140.3M182.3M218.8M240.4M269.4M348.6M755.6M41.4M60.2M59.1M
Shares outstanding30.5M30.5M30.4M30.4M30.4M29.3M41.5M35.9M35.4M32.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-39.9M-31.0M-18.7M-14.8M69.4M-65.1M-18.3M-16.5M-33.6M-46.0M
Capital spending-289.0K-1.30M-362.0K-585.0K-3.52M-3.73M-204.0K-122.0K-1.41M-4.75M
Free cash flow-40.2M-32.3M-19.1M-15.4M65.9M-68.9M-18.5M-16.7M-35.1M-50.8M
Cash from investing-289.0K-1.30M61.5M-63.9M-3.52M-3.73M674.8M-122.0K-1.41M-13.9M
Cash from financing-10.3M10.4M-9.00K0-67.0M-409.7M42.1M201.0K33.3M2.94M
Dividends paid0-75.0M00-75.0M00
Share buybacks0-14.0K08.00M-420.0M41.8M201.0K33.3M2.94M
Change in cash-47.1M-27.3M42.7M-79.7M-383.0K-477.2M698.8M-15.9M-2.56M-56.7M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 18, 2026Big-stake noticeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
10-Q · Quarterly reportNov 12, 2026Quarterly reportSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 28, 2026Insider tradeSEC
4 · Change in ownershipOct 28, 2026Insider tradeSEC
8-K · Current reportOct 26, 2026Management or board changeSEC
ARS · Annual report to shareholdersOct 2, 2026Annual reportSEC
DEF 14A · Proxy statementOct 2, 2026Meeting noticeSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
10-K/A · Annual report, amendedApr 29, 2026Annual reportSEC
10-K · Annual reportMar 13, 2026Annual reportSEC
S-8 · Registration statement for employee plansMar 11, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 23, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 23, 2026Big-stake noticeSEC
8-K · Current reportDec 9, 2025Management or board changeSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
8-K/A · Current report, amendedOct 15, 2025Management or board changeSEC
8-K · Current reportOct 3, 2025Material contractSEC
3 · Initial statement of ownershipSep 30, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 30, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 29, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 16, 2025Insider tradeSEC
8-K · Current reportSep 2, 2025Meeting outcomeSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
ARS · Annual report to shareholdersJul 7, 2025Annual reportSEC
DEF 14A · Proxy statementJul 7, 2025Meeting noticeSEC
8-K · Current reportJun 24, 2025Management or board changeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
10-K/A · Annual report, amendedApr 29, 2025Annual reportSEC
8-K · Current reportApr 7, 2025Current reportSEC
8-K · Current reportMar 31, 2025Management or board changeSEC
4 · Change in ownershipMar 19, 2025Insider tradeSEC
10-K · Annual reportMar 18, 2025Annual reportSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 27, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 27, 2025Big-stake noticeSEC
8-K · Current reportDec 31, 2024Management or board changeSEC
10-Q · Quarterly reportNov 13, 2024Quarterly reportSEC
10-Q · Quarterly reportAug 12, 2024Quarterly reportSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
8-K · Current reportJun 20, 2024Meeting outcomeSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
ARS · Annual report to shareholdersMay 1, 2024Annual reportSEC
DEFA14A · Additional proxy materialMay 1, 2024Meeting noticeSEC
DEF 14A · Proxy statementMay 1, 2024Meeting noticeSEC
10-K/A · Annual report, amendedMay 1, 2024Annual reportSEC
10-K/A · Annual report, amendedApr 24, 2024Annual reportSEC
10-K · Annual reportMar 15, 2024Annual reportSEC
SC 13G/A · Big-stake notice, amendedFeb 7, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 7, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 7, 2024Big-stake noticeSEC
4 · Change in ownershipJan 5, 2024Insider tradeSEC
8-K · Current reportJan 4, 2024Material contractSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
10-Q · Quarterly reportAug 11, 2023Quarterly reportSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
4 · Change in ownershipJun 26, 2023Insider tradeSEC
8-K · Current reportJun 23, 2023Meeting outcomeSEC
SC TO-I/AJun 20, 2023Acquisition or disposalSEC
SC TO-IMay 17, 2023Acquisition or disposalSEC
10-Q · Quarterly reportMay 10, 2023Quarterly reportSEC
ARS · Annual report to shareholdersApr 28, 2023Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2023Meeting noticeSEC
10-K · Annual reportMar 15, 2023Annual reportSEC
3 · Initial statement of ownershipFeb 23, 2023Insider tradeSEC
4 · Change in ownershipFeb 17, 2023Insider tradeSEC
8-K · Current reportFeb 14, 2023Management or board changeSEC
SC 13G · Big-stake noticeFeb 10, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 10, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 10, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeJan 12, 2023Big-stake noticeSEC
10-Q · Quarterly reportNov 9, 2022Quarterly reportSEC
10-Q · Quarterly reportAug 9, 2022Quarterly reportSEC
8-K · Current reportJun 29, 2022Meeting outcomeSEC
4 · Change in ownershipJun 27, 2022Insider tradeSEC
4 · Change in ownershipJun 27, 2022Insider tradeSEC
4 · Change in ownershipJun 27, 2022Insider tradeSEC
4 · Change in ownershipJun 27, 2022Insider tradeSEC
SC 13G · Big-stake noticeJun 16, 2022Big-stake noticeSEC
DEFA14A · Additional proxy materialMay 13, 2022Meeting noticeSEC
DEF 14A · Proxy statementMay 13, 2022Meeting noticeSEC
8-K · Current reportMay 13, 2022Current reportSEC
10-Q · Quarterly reportMay 10, 2022Quarterly reportSEC
10-K · Annual reportMar 15, 2022Annual reportSEC
SC 13G · Big-stake noticeFeb 15, 2022Big-stake noticeSEC
SC 13G · Big-stake noticeFeb 15, 2022Big-stake noticeSEC
4 · Change in ownershipFeb 15, 2022Insider tradeSEC
8-K · Current reportFeb 2, 2022Material contractSEC
4 · Change in ownershipJan 13, 2022Insider tradeSEC
SC 13G · Big-stake noticeJan 13, 2022Big-stake noticeSEC
4 · Change in ownershipNov 23, 2021Insider tradeSEC
4 · Change in ownershipNov 23, 2021Insider tradeSEC
10-Q · Quarterly reportNov 9, 2021Quarterly reportSEC
4 · Change in ownershipOct 15, 2021Insider tradeSEC
4 · Change in ownershipOct 6, 2021Insider tradeSEC
4 · Change in ownershipOct 1, 2021Insider tradeSEC
4 · Change in ownershipSep 28, 2021Insider tradeSEC
4 · Change in ownershipSep 22, 2021Insider tradeSEC
10-Q · Quarterly reportAug 9, 2021Quarterly reportSEC
4 · Change in ownershipJul 19, 2021Insider tradeSEC
4 · Change in ownershipJul 12, 2021Insider tradeSEC
4 · Change in ownershipJul 12, 2021Insider tradeSEC
8-K · Current reportJul 6, 2021Current reportSEC
4 · Change in ownershipJun 24, 2021Insider tradeSEC
4 · Change in ownershipJun 24, 2021Insider tradeSEC
4 · Change in ownershipJun 24, 2021Insider tradeSEC
4 · Change in ownershipJun 24, 2021Insider tradeSEC
10-Q · Quarterly reportMay 10, 2021Quarterly reportSEC
DEFA14A · Additional proxy materialApr 28, 2021Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2021Meeting noticeSEC
4/A · Change in ownership, amendedApr 27, 2021Insider tradeSEC
4 · Change in ownershipApr 27, 2021Insider tradeSEC
4 · Change in ownershipMar 22, 2021Insider tradeSEC
10-K · Annual reportMar 16, 2021Annual reportSEC
4 · Change in ownershipFeb 1, 2021Insider tradeSEC
SC 13G/A · Big-stake notice, amendedDec 23, 2020Big-stake noticeSEC
4 · Change in ownershipDec 18, 2020Insider tradeSEC
4 · Change in ownershipDec 2, 2020Insider tradeSEC
4 · Change in ownershipNov 20, 2020Insider tradeSEC
10-Q · Quarterly reportNov 9, 2020Quarterly reportSEC
S-8 · Registration statement for employee plansOct 2, 2020Offer documentSEC
4 · Change in ownershipSep 21, 2020Insider tradeSEC
4 · Change in ownershipSep 16, 2020Insider tradeSEC
4 · Change in ownershipSep 2, 2020Insider tradeSEC
4 · Change in ownershipSep 1, 2020Insider tradeSEC
4 · Change in ownershipSep 1, 2020Insider tradeSEC
4 · Change in ownershipSep 1, 2020Insider tradeSEC
4 · Change in ownershipSep 1, 2020Insider tradeSEC
4 · Change in ownershipAug 26, 2020Insider tradeSEC
4 · Change in ownershipAug 21, 2020Insider tradeSEC
10-Q · Quarterly reportAug 10, 2020Quarterly reportSEC
8-K · Current reportJun 29, 2020Meeting outcomeSEC
10-Q · Quarterly reportMay 11, 2020Quarterly reportSEC
DEFA14A · Additional proxy materialApr 29, 2020Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2020Meeting noticeSEC
4 · Change in ownershipMar 25, 2020Insider tradeSEC
4/A · Change in ownership, amendedMar 19, 2020Insider tradeSEC
4/A · Change in ownership, amendedMar 19, 2020Insider tradeSEC
4/A · Change in ownership, amendedMar 19, 2020Insider tradeSEC
10-K · Annual reportMar 16, 2020Annual reportSEC
4/A · Change in ownership, amendedMar 5, 2020Insider tradeSEC
4/A · Change in ownership, amendedFeb 19, 2020Insider tradeSEC
SC TO-I/AFeb 19, 2020Acquisition or disposalSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2020Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2020Big-stake noticeSEC
4 · Change in ownershipFeb 14, 2020Insider tradeSEC
3 · Initial statement of ownershipFeb 13, 2020Insider tradeSEC
4 · Change in ownershipFeb 13, 2020Insider tradeSEC
4 · Change in ownershipFeb 13, 2020Insider tradeSEC
4 · Change in ownershipFeb 13, 2020Insider tradeSEC
4 · Change in ownershipFeb 13, 2020Insider tradeSEC
SC 13G · Big-stake noticeFeb 13, 2020Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2020Big-stake noticeSEC
SC TO-I/AFeb 13, 2020Acquisition or disposalSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2020Big-stake noticeSEC
SC TO-I/AFeb 13, 2020Acquisition or disposalSEC
3 · Initial statement of ownershipFeb 11, 2020Insider tradeSEC
SC TO-I/AFeb 5, 2020Acquisition or disposalSEC
SC 13G/A · Big-stake notice, amendedJan 21, 2020Big-stake noticeSEC
SC TO-IJan 14, 2020Acquisition or disposalSEC
4 · Change in ownershipJan 9, 2020Insider tradeSEC
8-K · Current reportDec 30, 2019Acquisition or disposalSEC
4 · Change in ownershipDec 11, 2019Insider tradeSEC
8-K · Current reportDec 9, 2019Material contractSEC
4 · Change in ownershipDec 4, 2019Insider tradeSEC
10-Q · Quarterly reportNov 12, 2019Quarterly reportSEC
4 · Change in ownershipNov 8, 2019Insider tradeSEC
4 · Change in ownershipNov 8, 2019Insider tradeSEC
4 · Change in ownershipSep 9, 2019Insider tradeSEC
3 · Initial statement of ownershipSep 9, 2019Insider tradeSEC
10-Q · Quarterly reportAug 9, 2019Quarterly reportSEC
8-K · Current reportJul 16, 2019Management or board changeSEC
4 · Change in ownershipJul 1, 2019Insider tradeSEC
4 · Change in ownershipJul 1, 2019Insider tradeSEC
4 · Change in ownershipJul 1, 2019Insider tradeSEC
4 · Change in ownershipJun 28, 2019Insider tradeSEC
8-K · Current reportJun 20, 2019Meeting outcomeSEC
SC 13G/A · Big-stake notice, amendedJun 12, 2019Big-stake noticeSEC
4 · Change in ownershipJun 6, 2019Insider tradeSEC
8-K · Current reportJun 3, 2019Material contractSEC
424B5 · ProspectusJun 3, 2019Offer documentSEC
S-3MEFMay 31, 2019Other filingsSEC
424B5 · ProspectusMay 30, 2019Offer documentSEC
8-K · Current reportMay 30, 2019Current reportSEC
8-K · Current reportMay 30, 2019Current reportSEC
10-Q · Quarterly reportMay 9, 2019Quarterly reportSEC
8-K · Current reportMay 1, 2019Material contractSEC
424B5 · ProspectusMay 1, 2019Offer documentSEC

This page holds 200 of 410 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from XBiotech Inc.’s releases · as of Nov 12, 2026

Common shares
30,487,731
Fully diluted
30,487,731

Fully diluted

LineSharesAs of
Common shares30,487,731Nov 12, 2026

Share count over time

CountShares
Nov 12, 202630,487,731

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard333K1.1%US$729KSep 30, 2026
BlackRock318K1.0%US$695KSep 30, 2026
Geode Capital214K0.70%US$469KSep 30, 2026
RBF Capital, LLC199K0.65%US$435KSep 30, 2026
Morgan Stanley124K0.41%US$272KSep 30, 2026
Bridgeway Capital Management, LLC98,4470.32%US$216KSep 30, 2026
State Street73,0060.24%US$160KSep 30, 2026
Renaissance Technologies67,3550.22%US$148KSep 30, 2026
Northern Trust60,1230.20%US$132KSep 30, 2026
Empowered Funds, LLC59,5470.20%US$130KSep 30, 2026
All 32 holders
HolderSharesOf the companyValueAs of
Millennium58,6470.19%US$128KSep 30, 2026
BNY39,3550.13%US$86,188Sep 30, 2026
Gsa Capital Partners LLP37,9950.12%US$83,000Sep 30, 2026
Dimensional35,4910.12%US$77,703Sep 30, 2026
Allworth Financial LP34,7250.11%US$76,048Sep 30, 2026
Connor, Clark & Lunn Investment Management Ltd.27,9430.09%US$61,195Sep 30, 2026
BNP Paribas25,4000.08%US$55,626Sep 30, 2026
National Bank Of Canada25,0000.08%US$54,750Sep 30, 2026
Bank of America23,7890.08%US$52,098Sep 30, 2026
Squarepoint Ops LLC14,9410.05%US$32,721Sep 30, 2026
UBS14,3150.05%US$31,350Sep 30, 2026
American Century13,5100.04%US$29,587Sep 30, 2026
Qube Research & Technologies Ltd13,4850.04%US$29,532Sep 30, 2026
Pinnacle Financial Partners, Inc.11,7960.04%US$25,833Sep 30, 2026
RBC2,908<0.01%US$6,000Sep 30, 2026
McIlrath & Eck, LLC753<0.01%US$1,649Sep 30, 2026
Jones Financial Companies Lllp370<0.01%US$803Sep 30, 2026
JPMorgan96<0.01%US$209Sep 30, 2026
SBI Securities Co., Ltd.37<0.01%US$81Sep 30, 2026
Tower Research Capital LLC (TRC)25<0.01%US$55Sep 30, 2026
Larson Financial Group LLC21<0.01%US$46Sep 30, 2026
Caitong International Asset Management Co., Ltd14<0.01%US$31Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund200K0.66%US$460KJun 30, 2026
Fidelity Extended Market Index Fund111K0.36%US$267KMay 31, 2026
iShares Micro-Cap ETF78,5910.26%US$181KJun 30, 2026
EA Bridgeway Omni Small-Cap Value ETF56,5940.19%US$137KJun 30, 2026
Ultra-Small Company Fund38,9000.13%US$89,470Jun 30, 2026
Fidelity Total Market Index Fund35,1540.12%US$85,073May 31, 2026
Fidelity Series Total Market Index Fund27,5070.09%US$66,567May 31, 2026
Fidelity Nasdaq Composite Index Fund16,9600.06%US$41,043May 31, 2026
Avantis U.S. Small Cap Equity ETF13,2280.04%US$32,012May 31, 2026
JNL/DFA U.S. Small Cap Fund6,0660.02%US$13,952Jun 30, 2026
All 14 holders
HolderSharesOf the companyValueAs of
1290 VT Micro Cap Portfolio5,2900.02%US$12,167Jun 30, 2026
Avantis U.S. Small Cap Value ETF4,8710.02%US$11,788May 31, 2026
AST Small-Cap Equity Portfolio2,660<0.01%US$6,118Jun 30, 2026
Avantis U.S. Small Cap Value Fund282<0.01%US$682May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Simard John
Director, 10% owner
Buy70,000USD 2.05US$143KNov 3, 2026
Simard John
Director, 10% owner
Buy368,524USD 1.93US$711KOct 26, 2026

Big stakes

StakeStakeSharesDateFiling
John Simard17.70%5.72MDec 31, 2025Schedule 13G
W. Thorpe McKenzie8.40%2.57MNov 16, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Daniel Vasella
Other companies: American Express Company (Director · Since at least Jul 19, 2012); PepsiCo, Inc. (Director · Since at least Oct 1, 2006)
Director · Apr 14, 2015 – Jun 19, 2017 · Past
Benjamin GuzmanSr.VP Corp. Strategy & Finance · Jul 1, 2017 – Jul 7, 2017 · Past
Craig Evan RademakerDirector · Since at least Aug 29, 2025
David Spencer SofferDirector · Since at least Aug 29, 2025
Dawn McColloughVP Clinical Operations · May 16, 2016 – May 19, 2016 · Past
Donald H MacAdamDirector · Mar 20, 2018 – Jun 20, 2024 · Past
Jan-Paul WaldinDirector · Feb 27, 2018 – Jun 20, 2024 · Past
John SimardDirector · Since at least Oct 23, 2026
Kelly ThornburgSVP of Operations · Jun 8, 2015 – Jun 8, 2015 · Past
Mike CavalierVice President of Manufacturing · Since at least Nov 4, 2026
All 18 people
PersonSeat
Norma GonzalezVice President of Quality · Since at least Nov 5, 2026
Peter LibbyDirector · Jul 10, 2019 – Jun 20, 2024 · Past
Qian WuSenior Vice President of Clinical Operations and Analytical Quality · Since at least Nov 5, 2026
Queena HanVP Finance & HR · Apr 14, 2015 – Nov 19, 2021 · Past
Sushma ShivaswamyChief Scientific Officer, Interim Chief Executive Officer · Since at least Feb 10, 2023
Tevi David TroyDirector · Since at least Aug 29, 2025
Thomas Martin KuendigDirector · Since at least Aug 29, 2025
W Thorpe McKenzieDirector · Apr 14, 2015 – Jun 20, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about XBiotech Inc.